HERANOVA
Live / Allowed — Notice of allowance issued (as of 02 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Oct 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98831068
- Mark type
- Stylized text
- Filed
- 31 Oct 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Y. Jae Kim
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseases, namely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment plan, as well as the composition of microbiome, including presence of normal lactobacillus and targeted pathogenic bacteria, namely, Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterial, fungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseases, namely, primary ovarian insufficiency; Pharmaceuticals, namely, therapeutic drugs for treating endometriosis, infertility, and gynecological diseases and disorders
- Class 010 — Medical apparatus: Medical devices, namely, surgical and nonsurgical devices for treating endometriosis, infertility, and gynecological diseases and disorders.
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecology, namely, testing services for detecting endometritis, a woman's personalized embryo implantation time, and/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disorders, namely, for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment services, namely, health assessment of a patient's remaining childbearing years based on patient-specific health information.
Owner
- Heranova Lifesciences Inc., Burlington, MA, US
- Heranova Lifesciences Inc., Burlington, MA, US
Prosecution history
- 02 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 May 2025 — NON-FINAL ACTION E-MAILED
- 08 May 2025 — NON-FINAL ACTION WRITTEN
- 05 May 2025 — ASSIGNED TO EXAMINER
- 04 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Oct 2024 — NEW APPLICATION ENTERED